178 related articles for article (PubMed ID: 27998070)
41. Chain conformation transition induced host-guest assembly between triple helical curdlan and β-CD for drug delivery.
Liu Q; Yang D; Shang T; Guo L; Yang B; Xu X
Biomater Sci; 2020 Mar; 8(6):1638-1648. PubMed ID: 31970339
[TBL] [Abstract][Full Text] [Related]
42. SDS-aided immobilization and controlled release of camptothecin from agarose hydrogel.
Liu J; Li L
Eur J Pharm Sci; 2005 Jun; 25(2-3):237-44. PubMed ID: 15911219
[TBL] [Abstract][Full Text] [Related]
43. Dimeric camptothecin derived phospholipid assembled liposomes with high drug loading for cancer therapy.
Fang S; Hou Y; Ling L; Wang D; Ismail M; Du Y; Zhang Y; Yao C; Li X
Colloids Surf B Biointerfaces; 2018 Jun; 166():235-244. PubMed ID: 29604567
[TBL] [Abstract][Full Text] [Related]
44. Hydrotropic hyaluronic acid conjugates: Synthesis, characterization, and implications as a carrier of paclitaxel.
Saravanakumar G; Choi KY; Yoon HY; Kim K; Park JH; Kwon IC; Park K
Int J Pharm; 2010 Jul; 394(1-2):154-61. PubMed ID: 20438818
[TBL] [Abstract][Full Text] [Related]
45. Chitosan stabilized camptothecin nanoemulsions: Development, evaluation and biodistribution in preclinical breast cancer animal mode.
Natesan S; Sugumaran A; Ponnusamy C; Thiagarajan V; Palanichamy R; Kandasamy R
Int J Biol Macromol; 2017 Nov; 104(Pt B):1846-1852. PubMed ID: 28545970
[TBL] [Abstract][Full Text] [Related]
46. Incorporation of camptothecin into N-phthaloyl chitosan-g-mPEG self-assembly micellar system.
Opanasopit P; Ngawhirunpat T; Chaidedgumjorn A; Rojanarata T; Apirakaramwong A; Phongying S; Choochottiros C; Chirachanchai S
Eur J Pharm Biopharm; 2006 Nov; 64(3):269-76. PubMed ID: 16870407
[TBL] [Abstract][Full Text] [Related]
47. Controlled release and reversal of multidrug resistance by co-encapsulation of paclitaxel and verapamil in solid lipid nanoparticles.
Baek JS; Cho CW
Int J Pharm; 2015 Jan; 478(2):617-24. PubMed ID: 25510604
[TBL] [Abstract][Full Text] [Related]
48. Fabrication and characterization of photoluminescent silicon nanoparticles for drug delivery applications.
Ryu J; Cho B; Woo HG; Cho S; Sohn H
J Nanosci Nanotechnol; 2013 Jan; 13(1):157-60. PubMed ID: 23646711
[TBL] [Abstract][Full Text] [Related]
49. Design and evaluation of glutathione responsive glycosylated camptothecin nanosupramolecular prodrug.
Li W; Chen Z; Liu X; Lian M; Peng H; Zhang C
Drug Deliv; 2021 Dec; 28(1):1903-1914. PubMed ID: 34519602
[TBL] [Abstract][Full Text] [Related]
50. Amphiphilic star PEG-Camptothecin conjugates for intracellular targeting.
Omar R; Bardoogo YL; Corem-Salkmon E; Mizrahi B
J Control Release; 2017 Jul; 257():76-83. PubMed ID: 27677603
[TBL] [Abstract][Full Text] [Related]
51. Camptothecin nanocolloids based on N,N,N-trimethyl chitosan: efficient suppression of growth of multiple myeloma in a murine model.
Li Z; Li X; Cao Z; Xu Y; Lin H; Zhao Y; Wei Y; Qian Z
Oncol Rep; 2012 Apr; 27(4):1035-40. PubMed ID: 22245938
[TBL] [Abstract][Full Text] [Related]
52. General Reagent Free Route to pH Responsive Polyacryloyl Hydrazide Capped Metal Nanogels for Synergistic Anticancer Therapeutics.
Ujjwal RR; Purohit MP; Patnaik S; Ojha U
ACS Appl Mater Interfaces; 2015 Jun; 7(21):11497-507. PubMed ID: 25961335
[TBL] [Abstract][Full Text] [Related]
53. Rational Design of a New Self-Codelivery System from Redox-Sensitive Camptothecin-Cytarabine Conjugate Assembly for Effectively Synergistic Anticancer Therapy.
He W; Hu X; Jiang W; Liu R; Zhang D; Zhang J; Li Z; Luan Y
Adv Healthc Mater; 2017 Dec; 6(24):. PubMed ID: 29076266
[TBL] [Abstract][Full Text] [Related]
54. Stealth and non-stealth nanocapsules containing camptothecin: in-vitro and in-vivo activity on B16-F10 melanoma.
Loch-Neckel G; Nemen D; Puhl AC; Fernandes D; Stimamiglio MA; Alvarez Silva M; Hangai M; Santos Silva MC; Lemos-Senna E
J Pharm Pharmacol; 2007 Oct; 59(10):1359-64. PubMed ID: 17910810
[TBL] [Abstract][Full Text] [Related]
55. Stealth CD44-targeted hyaluronic acid supramolecular nanoassemblies for doxorubicin delivery: probing the effect of uncovalent pegylation degree on cellular uptake and blood long circulation.
Han X; Li Z; Sun J; Luo C; Li L; Liu Y; Du Y; Qiu S; Ai X; Wu C; Lian H; He Z
J Control Release; 2015 Jan; 197():29-40. PubMed ID: 25449802
[TBL] [Abstract][Full Text] [Related]
56. Synergistic antitumor activity of a self-assembling camptothecin and capecitabine hybrid prodrug for improved efficacy.
Ma W; Su H; Cheetham AG; Zhang W; Wang Y; Kan Q; Cui H
J Control Release; 2017 Oct; 263():102-111. PubMed ID: 28082170
[TBL] [Abstract][Full Text] [Related]
57. Supramolecular nanoparticles based on β-CD modified hyaluronic acid for DNA encapsulation and controlled release.
Yang Y; Jia X; Zhang YM; Li N; Liu Y
Chem Commun (Camb); 2018 Aug; 54(63):8713-8716. PubMed ID: 30023992
[TBL] [Abstract][Full Text] [Related]
58. Co-delivery of small interfering RNA using a camptothecin prodrug as the carrier.
Tang Q; Cao B; Cheng G
Chem Commun (Camb); 2014 Feb; 50(11):1323-5. PubMed ID: 24343195
[TBL] [Abstract][Full Text] [Related]
59. Poly(ethylene glycol) shell-sheddable nanomicelle prodrug of camptothecin with enhanced cellular uptake.
Wu Q; Du F; Luo Y; Lu W; Huang J; Yu J; Liu S
Colloids Surf B Biointerfaces; 2013 May; 105():294-302. PubMed ID: 23384692
[TBL] [Abstract][Full Text] [Related]
60. Development of polymeric and cyclodextrin nanoparticles for camptothecin delivery.
Cirpanli Y; Bilensoy E; Dogan AL; Calis S
J Control Release; 2010 Nov; 148(1):e21-3. PubMed ID: 21529600
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
